Search results for "mortality [Cerebellar Neoplasms]"

showing 10 items of 472 documents

2017

Summary Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015. Methods…

Gerontologymedicine.medical_specialtyIndex (economics)business.industryMortality ratePublic health1. No povertyGeneral Medicine030204 cardiovascular system & hematologyPer capita income3. Good health03 medical and health sciences0302 clinical medicineScale (social sciences)Health careGlobal healthmedicineLife expectancy030212 general & internal medicinebusinessDemographyThe Lancet
researchProduct

2017

Abstract Background The burden of cardiovascular diseases (CVDs) remains unclear in many regions of the world. Objectives The GBD (Global Burden of Disease) 2015 study integrated data on disease incidence, prevalence, and mortality to produce consistent, up-to-date estimates for cardiovascular burden. Methods CVD mortality was estimated from vital registration and verbal autopsy data. CVD prevalence was estimated using modeling software and data from health surveys, prospective cohorts, health system administrative data, and registries. Years lived with disability (YLD) were estimated by multiplying prevalence by disability weights. Years of life lost (YLL) were estimated by multiplying age…

Gerontologymedicine.medical_specialtybusiness.industryMortality rate1. No povertyDisease030204 cardiovascular system & hematologyVerbal autopsy3. Good health03 medical and health sciences0302 clinical medicineYears of potential life lostEnvironmental healthEpidemiologyGlobal healthmedicineLife expectancy030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessCause of deathJournal of the American College of Cardiology
researchProduct

2017

Summary Background As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. Methods We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between inc…

Gerontologymedicine.medical_specialtybusiness.industryMortality rateIncidence (epidemiology)1. No povertyPrevalenceGeneral Medicinemedicine.diseaseComorbidity3. Good health03 medical and health sciences0302 clinical medicineEpidemiologyGlobal healthmedicineLife expectancy030212 general & internal medicine10. No inequalitybusiness030217 neurology & neurosurgeryDepression (differential diagnoses)DemographyThe Lancet
researchProduct

Do different models induce changes in mortality indicators? That is a key question for extending the Lee-Carter model

2021

[EN] The parametric model introduced by Lee and Carter in 1992 for modeling mortality rates in the USA was a seminal development in forecasting life expectancies and has been widely used since then. Different extensions of this model, using different hypotheses about the data, constraints on the parameters, and appropriate methods have led to improvements in the model's fit to historical data and the model's forecasting of the future. This paper's main objective is to evaluate if differences between models are reflected in different mortality indicators' forecasts. To this end, nine sets of indicator predictions were generated by crossing three models and three block-bootstrap samples with …

Health Toxicology and MutagenesisPopulationESTADISTICA E INVESTIGACION OPERATIVALee–Carter modellcsh:MedicineSample (statistics)forecastingHG01 natural sciencesArticle010104 statistics & probabilityLife ExpectancyMortality indicators0502 economics and businessEconometrics0101 mathematicsMortalityeducationBlock-bootstrapMathematicsProbabilityfunctional ANOVAeducation.field_of_study050208 financeModels StatisticalLee Carter models block-bootstrap functional ANOVA forecasting mortality indicatorsMortality rate05 social scienceslcsh:RPublic Health Environmental and Occupational Healthblock-bootstrapFunctional ANOVAMortality dataParametric modelmortality indicatorsAnalysis of varianceLee-Carter modelsForecasting
researchProduct

Pilot study on the combination of an organophosphate-based insecticide paint and pyrethroid-treated long lasting nets against pyrethroid resistant ma…

2015

International audience; A pilot study to test the efficacy of combining an organophosphate-based insecticide paint and pyrethroid-treated Long Lasting Insecticide Treated Nets (LLINs) against pyrethroid-resistant malaria vector mosquitoes was performed in a real village setting in Burkina Faso. Paint Inesfly 5A IGR™, comprised of two organophosphates (OPs) and an Insect Growth Regulator (IGR), was tested in combination with pyrethroid-treated LLINs. Efficacy was assessed in terms of mortality for 12 months using Early Morning Collections of malaria vectors and 30-minute WHO bioassays. Resistance to pyrethroids and OPs was assessed by detecting the frequency of L1014F and L1014S kdr mutation…

Insecticideshttp://aims.fao.org/aos/agrovoc/c_8081Mosquito ControlPyridinesLLINsPilot ProjectsToxicologyInsecticide Resistancechemistry.chemical_compoundPaintPyrethrinsInesfly 5A IGR™Malaria vector2. Zero hungerPyrethroidMortality rateOrganophosphate000 - Autres thèmesOrganophosphatesAnopheles coluzzii3. Good healthInesfly 5A IGR (TM)Juvenile HormonesInfectious DiseasesDiazinonChlorpyrifosL72 - Organismes nuisibles des animauxLong lastingPyrethroid resistanceMalaria controlVeterinary (miscellaneous)Enzyme-Linked Immunosorbent AssayBiologyInsect growth regulatorAnophelesBurkina Fasoparasitic diseasesmedicineAnimalsHumansInsecticide-Treated Bednetsmedicine.diseaseBlood mealInsect VectorsMalariachemistryInsect ScienceParasitologyMalaria[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

The Obesity Paradox Predicts the Second Wave of COVID-19 to Be Severe in Western Countries.

2021

While COVID-19 infection and mortality rates are soaring in Western countries, Southeast Asian countries have successfully avoided the second wave of the SARS-CoV-2 pandemic despite high population density. We provide a biochemical hypothesis for the connection between low COVID-19 incidence, mortality rates, and high visceral adiposity in Southeast Asian populations. The SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) as a gateway into the human body. Although the highest expression levels of ACE2 are found in people’s visceral adipose tissue in Southeast Asia, this does not necessarily make them vulnerable to COVID-19. Hypothetically, high levels of visceral adiposity cause s…

Intra-Abdominal FatHealth Toxicology and Mutagenesislcsh:MedicinePhysiologyAdipose tissueACE2030209 endocrinology & metabolismIntra-Abdominal FatPeptidyl-Dipeptidase ASoutheast asianSystemic inflammationWhite People03 medical and health sciences0302 clinical medicineAsian PeopleMedicineHumansObesityvisceral adipose tissuePandemicsAsia Southeastern030304 developmental biologyAdiposityInflammationsystemic inflammation0303 health sciencesbusiness.industrySARS-CoV-2Mortality rateIncidencelcsh:RCOVID-19 ; visceral adipose tissue ; systemic inflammation ; SARS-CoV-2 ; ACE2 ; weight gain ; second wave ; Quarantine-15Public Health Environmental and Occupational HealthCOVID-19weight gainmedicine.diseaseObesitysecond waveQuarantine-15PerspectiveAngiotensin-Converting Enzyme 2medicine.symptombusinessWeight gainObesity paradoxInternational journal of environmental research and public health
researchProduct

Medida del resultado de las intervenciones sanitarias en España: una aproximación mediante el análisis temporal y espacial de la mortalidad evitable …

2006

Fundamento: Muchos estudios proponen la mortalidad evitable (ME) como indicador para monitorizar los servicios de salud aunque su generalización está limitada por el gran número de listas de causas utilizadas. El objetivo es analizar la evolución temporal del período 1986-2001 y la distribución geográfica de la mortalidad evitable utilizando una lista de causas consensuada. Métodos: Se analiza la mortalidad evitable global (ME) y agrupada en causas ISAS (intervenciones de los servicios sanitarios) y causas IPSI (políticas intersectoriales). Se analiza la evolución temporal ajustando una recta de regresión de Poisson o un modelo de regresión de Joinpoint, según el caso, y se estima el porcen…

Joinpoint regressionbusiness.industryTime trendsCausa de muerteMortality ratelcsh:Public aspects of medicinelcsh:Rlcsh:Medicinelcsh:RA1-1270General MedicineAvoidable mortalityHealth servicesMedicineIndicadores de calidadServicios de saludbusinessHealth policyDemographyMortalidad prematura
researchProduct

Laparoscopic distal pancreatectomy: what factors are related to the learning curve?

2014

none 7 no PURPOSE: The factors related to the learning curve for laparoscopic distal pancreatectomy have rarely been evaluated. METHODS: A retrospective study of 32 patients who underwent a laparoscopic distal pancreatectomy performed at a high-volume center by a single pancreatic surgeon experienced with laparoscopic surgery was conducted. Pre-, intra- and postoperative data were collected. The primary endpoint was the length of the operation. The secondary endpoints were the conversion and reoperation rates, overall postoperative morbidity and mortality rates, the length of hospital stay and rate of unplanned splenectomy. RESULTS: The length of the operation and the cumulative sum of the …

Laparoscopic surgeryAdultMaleReoperationmedicine.medical_specialtyAdult; Aged; Databases Factual; Female; Humans; Laparoscopy; Length of Stay; Male; Middle Aged; Multivariate Analysis; Operative Time; Pancreatectomy; Reoperation; Retrospective Studies; Splenectomy; Survival Rate; Learning Curve; Medicine (all)Databases FactualLaparoscopy pancreas learningmedicine.medical_treatmentEndocrinology Diabetes and MetabolismSplenectomyOperative TimeDatabasesPancreatectomyRetrospective StudiemedicineClinical endpointHumansLaparoscopySurvival rateMultivariate AnalysiFactualRetrospective StudiesAgedmedicine.diagnostic_testHepatologybusiness.industryGeneral surgeryMortality rateMedicine (all)GastroenterologyRetrospective cohort studyGeneral MedicineLength of StayMiddle AgedSurgerySurvival RateSettore MED/18 - Chirurgia GeneralePancreatectomyMultivariate AnalysisSplenectomySurgeryFemaleLaparoscopybusinessLearning CurveHuman
researchProduct

La ejemplaridad de la muerte y la inmortalidad del saber en la literatura sapiencial medieval

2022

El origen escriturario de la muerte como castigo es el punto de partida de su ejemplaridad que, basada en presupuestos teológicos, le imprimió un halo de penitencia, que se perfila en todos los órdenes de actuación y convivencia del ser humano, en aras de conseguir el perdón y retornar a la gracia divina. En este trabajo se analizan los diferentes motivos que proyectan la ejemplaridad de la muerte en el ámbito de la literatura sapiencial: muerte física y muerte espiritual; trascendencia y sentencia del alma; el hecho maravilloso (milagros, premoniciones, relevaciones o visiones); el miedo (y lo macabro) ligado al arquetipo de la muerte transida y sus plasmaciones en variados tópicos (mement…

Literature and Literary TheoryVisual Arts and Performing ArtsEjemplaridadExemplaritySoulLiteratura castellanaFama póstumaWisdom LiteratureFearInmortalidad del saberDeathArts and Humanities (miscellaneous)Literatura sapiencialMuertePosthumous fameImmortality of knowledgeLiteratureMiedoLiteraturaAlmaPhilologyMortMusicFilología
researchProduct

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017 : a systematic analysis for the Global Bu…

2020

Background\ud \ud Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in this paper) are a major cause of morbidity and mortality globally, although the burden and underlying causes differ across locations and demographic groups. We report on results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 on the burden of cirrhosis and its trends since 1990, by cause, sex, and age, for 195 countries and territories.\ud \ud \ud \ud Methods\ud \ud We used data from vital registrations, vital registration samples, and verbal autopsies to estimate mortality. We modelled prevalence of total, compensated, and decompensated cirrhosis on the bas…

Liver CirrhosisMaleCirrhosisCost-Benefit AnalysisHEPATITIS-BGlobal Burden of DiseaseLiver diseaseDisability Evaluation0302 clinical medicineBurden Global Mortality CirrhosisNon-alcoholic Fatty Liver DiseaseRisk FactorsFIBROSISEurope EasternPOPULATIONAged 80 and overeducation.field_of_studySingaporeMortality rate1. No povertyGastroenterologyHepatitis CHepatitis BMiddle AgedHepatitis BHepatitis C3. Good healthPREVALENCE030220 oncology & carcinogenesisAsia Central030211 gastroenterology & hepatologyEgyptFemaleQuality-Adjusted Life YearsViral hepatitisLife Sciences & BiomedicineAdultEUROPEPopulationGBD 2017 Cirrhosis CollaboratorsArticle03 medical and health sciencesLIVER-DISEASEmedicineHumanseducationLiver Diseases AlcoholicAfrica South of the SaharaAgedScience & TechnologyHepatologyGastroenterology & Hepatologybusiness.industryMORTALITYDISABILITYDECOMPENSATIONmedicine.diseaseYears of potential life lostEarly DiagnosisSocioeconomic Factors3121 General medicine internal medicine and other clinical medicineINJURIESHuman medicinebusinessDemographyRCLancet gastroenterology & hepatology
researchProduct